Inicio
El gran evento español dedicado a la salud cardiovascular. Oferta formativa con 140 sesiones, 1000 comunicaciones y 4000 participantes
El gran evento español dedicado a la salud cardiovascular. Oferta formativa con 140 sesiones, 1000 comunicaciones y 4000 participantes
AbstractBackgroundStatins are highly effective for primary prevention of atherosclerotic cardiovascular disease (ASCVD) and mortality. Data on the benefit of statins in adults with heart failure…
AbstractBackgroundLipoprotein(a) (Lp[a]) is a causal genetic risk factor for atherosclerotic cardiovascular disease (ASCVD). There are limited long-term follow-up data from large U.S. population co…
AbstractBackgroundLipoprotein(a) (Lp[a]) is a causal genetic risk factor for atherosclerotic cardiovascular disease (ASCVD). There are limited long-term follow-up data from large U.S. population co…
European Journal of Heart Failure is an ESC journal dedicated to improving the understanding, prevention, investigation and treatment of heart failure.
European Journal of Heart Failure is an ESC journal dedicated to improving the understanding, prevention, investigation and treatment of heart failure.
AbstractBackgroundAlthough beta-blockers are not recommended for the treatment of heart failure with preserved ejection fraction (HFpEF) according to the latest European Society of Cardiology and…
Statins cause a moderate dose-dependent increase in new diagnoses of diabetes that is consistent with a small upwards shift in glycaemia, with the majority of…
Common pathophysiological mechanisms are observed in HFpEF and functional MR, such as diastolic dysfunction, preserved EF, atrial dilation and dysfunction, and annular remodeling. However, less…
European Journal of Heart Failure is an ESC journal dedicated to improving the understanding, prevention, investigation and treatment of heart failure.
European Journal of Heart Failure is an ESC journal dedicated to improving the understanding, prevention, investigation and treatment of heart failure.